-
The anti-arrhythmic dronedarone has been approved by the FDA for maintenance of normal sinus rhythm in patients with a history of atrial fibrillation or atrial flutter.
-
The FDA has approved prasugrel, a new oral antiplatelet agent for use in preventing thrombosis in patients with acute coronary syndrome who are to be managed by angioplasty.
-
Two papers presented at the recent American Society of Clinical Oncology (ASCO) have brought to light to potential serious drug interaction between tamoxifen and several commonly used SSRI antidepressants.
-
The FDA has approved a single-dose formulation of Plan B, the emergency contraceptive previously available in a two-tablet dose.
-
Two new programs have been announced by Merck & Co. to help confirm patients' insurance coverage and address providers' reimbursement concerns regarding Gardasil, the quadrivalent human papillomavirus (HPV) vaccine.
-
-
Although still controversial, pooling of data from randomized trials suggests the neuroprotective benefit of magnesium sulfate in patients in preterm labor prior to 34 weeks of gestation.
-
This paper describes the results of an epidemiologic survey of the results of in-hospital cardiopulmonary resuscitation (CPR) in U.S. hospitals.
-
Patients who receive proton-pump inhibitors in the hospital are at increased risk for hospital-acquired pneumonia.
-
This meta-analysis of 12 clinical trials in adult patients with acute respiratory failure showed that extubation directly to non-invasive ventilation before weaning would normally have been attempted decreases mortality, ventilator-associated pneumonia, and length of stay especially for patients with COPD.